NCT04685486 Virtual Reality for Pain Management in Burn Patients
| NCT ID | NCT04685486 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Weill Medical College of Cornell University |
| Condition | Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2018-06-01 |
| Primary Completion | 2027-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2018-06-01 with a primary completion date of 2027-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a randomized proof-of-concept study to assess the efficacy of Virtual Reality (VR) vs standard of care in 50 adult patients in the New York Presbyterian Burn Unit. The participants who are randomized to receive the virtual reality intervention will also receive opioids, which is the standard of care and is known to be effective. Participants will be randomly assigned to two groups. The first group will receive VR during their painful procedure (e.g., wound dressing changes, physical therapy etc.) in addition to the standard of care. The other group will receive standard of care (and no VR).
Eligibility Criteria
Inclusion Criteria: * 8 years and older * Patients with a burn injury and is in the Burn Unit at New York Presbyterian * Awake, alert, ambulatory * The burn comprises less than 15% total body surface area (TBSA) * The patient does not require conscious sedation such as ketamine for staple removal or wound dressing changes * The patient is able to give informed consent Exclusion Criteria: * Diagnosis of a cognitive disorder, psychotic disorder or bipolar I as determined by self-report from previous diagnosis * Current opioid abuse
Contact & Investigator
JoAnn Difede, PhD
PRINCIPAL INVESTIGATOR
Weill Medical College of Cornell University
Frequently Asked Questions
Who can join the NCT04685486 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, studying Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04685486 currently recruiting?
Yes, NCT04685486 is actively recruiting participants. Contact the research team at olb4002@med.cornell.edu for enrollment information.
Where is the NCT04685486 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT04685486 clinical trial?
NCT04685486 is sponsored by Weill Medical College of Cornell University. The principal investigator is JoAnn Difede, PhD at Weill Medical College of Cornell University. The trial plans to enroll 50 participants.